Department of Surgery, Loyola University Medical Center, Maywood, IL. Electronic address: https://twitter.com/psweigert.
Department of Surgery, Loyola University Medical Center, Maywood, IL.
Surgery. 2021 Sep;170(3):880-888. doi: 10.1016/j.surg.2021.02.021. Epub 2021 Mar 23.
Textbook oncologic outcome has been described in an effort to improve upon traditional outcomes defining care after pancreaticoduodenectomy for adenocarcinoma. We sought to examine whether minimally invasive pancreaticoduodenectomy increased the likelihood of an optimal textbook oncologic outcome.
Patients undergoing open pancreaticoduodenectomy or minimally invasive pancreaticoduodenectomy between 2010 and 2015 were identified in the National Cancer Database. Textbook oncologic outcome was defined as R0 resection with American Joint Committee on Cancer compliant lymphadenectomy, no prolonged duration of stay, no 30-day readmission/mortality, and receipt of adjuvant chemotherapy. Propensity score matching was employed to evaluate adjusted rates of textbook oncologic outcome, in addition to overall survival.
Among 12,854 patients who underwent pancreaticoduodenectomy, 48.3% were female, and the median patient age was 66 years; 87.5% underwent open pancreaticoduodenectomy, and 12.5% underwent whether minimally invasive pancreaticoduodenectomy. After propensity score matching, there were no noted differences in the likelihood of R0 resection, adequate lymphadenectomy, nonprolonged duration of stay, no readmission, no 30-day mortality, adjuvant chemotherapy, or textbook oncologic outcome among open pancreaticoduodenectomy versus minimally invasive pancreaticoduodenectomy (P > .05). Textbook oncologic outcome was associated with an improved median overall survival (negative textbook oncologic outcome: 21.3 months vs positive textbook oncologic outcome: 27.6 months, P < .001).
Although textbook oncologic outcome was associated with a survival advantage, it was only achieved in 1 in 4 patients undergoing pancreaticoduodenectomy for adenocarcinoma. Achievement of textbook oncologic outcome was equivalent among patients who underwent minimally invasive pancreaticoduodenectomy compared with open pancreaticoduodenectomy after propensity score matching.
为了改善胰腺十二指肠切除术治疗腺癌的传统预后,已经描述了教科书式的肿瘤学结果。我们试图研究微创胰腺十二指肠切除术是否增加了获得最佳教科书式肿瘤学结果的可能性。
在国家癌症数据库中确定了 2010 年至 2015 年间接受开放胰腺十二指肠切除术或微创胰腺十二指肠切除术的患者。教科书式的肿瘤学结果定义为 R0 切除,具有美国癌症联合委员会(AJCC)规定的淋巴结清扫术,没有延长住院时间,没有 30 天再入院/死亡率,并且接受辅助化疗。采用倾向评分匹配来评估调整后的教科书肿瘤学结果和总生存率。
在接受胰腺十二指肠切除术的 12854 名患者中,48.3%为女性,中位患者年龄为 66 岁;87.5%接受开放胰腺十二指肠切除术,12.5%接受微创胰腺十二指肠切除术。在进行倾向评分匹配后,开放胰腺十二指肠切除术与微创胰腺十二指肠切除术之间,R0 切除、充分淋巴结清扫、无延长住院时间、无再入院、无 30 天死亡率、辅助化疗或教科书肿瘤学结果的可能性均无显著差异(P >.05)。教科书式的肿瘤学结果与中位总生存率的提高相关(负面教科书式肿瘤学结果:21.3 个月;正面教科书式肿瘤学结果:27.6 个月,P <.001)。
尽管达到了教科书式的肿瘤学结果与生存优势相关,但只有 1/4 的接受胰腺十二指肠切除术治疗腺癌的患者达到了这一目标。在倾向评分匹配后,微创胰腺十二指肠切除术与开放胰腺十二指肠切除术相比,达到了教科书式的肿瘤学结果的比例相当。